Ching

FTC Order Stops the Marketer of “Thrive” Supplement from Making Baseless Claims It Can Treat, Prevent, or Reduce the Risks from COVID-19

Retrieved on: 
Friday, July 10, 2020
Human sexuality, Rape, Sexual consent, Ching, Humans

The FTC proposed order also bars the marketer of Thrive, Marc Ching, from making similarly unsupported cancer treatment or prevention claims for products containing CBD.

Key Points: 
  • The FTC proposed order also bars the marketer of Thrive, Marc Ching, from making similarly unsupported cancer treatment or prevention claims for products containing CBD.
  • The case against Ching is the FTCs first against a marketer of a supposed COVID-19-related health product.
  • In April 2020, the FTC announced that Ching agreed to a preliminary federal court order that imposed similar terms.
  • When the Commission issues a consent order on a final basis, it carries the force of law with respect to future actions.

FTC Order Stops the Marketer of “Thrive” Supplement from Making Baseless Claims It Can Treat, Prevent, or Reduce the Risks from COVID-19

Retrieved on: 
Friday, July 10, 2020
Human sexuality, Rape, Sexual consent, Ching, Humans

The FTC proposed order also bars the marketer of Thrive, Marc Ching, from making similarly unsupported cancer treatment or prevention claims for products containing CBD.

Key Points: 
  • The FTC proposed order also bars the marketer of Thrive, Marc Ching, from making similarly unsupported cancer treatment or prevention claims for products containing CBD.
  • The case against Ching is the FTCs first against a marketer of a supposed COVID-19-related health product.
  • In April 2020, the FTC announced that Ching agreed to a preliminary federal court order that imposed similar terms.
  • When the Commission issues a consent order on a final basis, it carries the force of law with respect to future actions.